CTC Alternative Strategies’s Insmed INSM Stock Holding History

CTC Alternative Strategies’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,850	Closed	-$410K	–	66
2025 Q3	$410K	Buy	+2,850	New	+$349K	0.66%	47

Other funds holding INSM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

CTC Alternative Strategies's INSM Position: Q4 2025 in Review

CTC Alternative Strategies sold out of Insmed (INSM) in Q4 2025, closing a stake of 2,850 shares — an estimated $410K sold.

CTC Alternative Strategies first reported a position in INSM in Q3 2025 and held it in 1 quarter. The position peaked at $410K in Q3 2025. 678 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

CTC Alternative Strategies reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
CTC Alternative Strategies sold 2,850 Insmed shares in Q4 2025, an estimated $410K.
CTC Alternative Strategies first reported a position in Insmed in Q3 2025 and held it in 1 quarter.
CTC Alternative Strategies's Insmed position peaked at $410K in Q3 2025.
678 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on CTC Alternative Strategies's 13F filing for Q4 2025, filed 18 Feb 2026.